These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 23613724)

  • 41. Complement Factor H-Related Protein 4A Is the Dominant Circulating Splice Variant of
    Pouw RB; Brouwer MC; van Beek AE; Józsi M; Wouters D; Kuijpers TW
    Front Immunol; 2018; 9():729. PubMed ID: 29719534
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Deletion Variants of
    Jullien P; Laurent B; Claisse G; Masson I; Dinic M; Thibaudin D; Berthoux F; Alamartine E; Mariat C; Maillard N
    J Am Soc Nephrol; 2018 Feb; 29(2):661-669. PubMed ID: 29114042
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Plasma levels of complement activation fragments C3b and sC5b-9 significantly increased in patients with thrombotic microangiopathy after allogeneic stem cell transplantation.
    Qi J; Wang J; Chen J; Su J; Tang Y; Wu X; Ma X; Chen F; Ruan C; Zheng XL; Wu D; Han Y
    Ann Hematol; 2017 Nov; 96(11):1849-1855. PubMed ID: 28801815
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Factor H autoantibody is associated with atypical hemolytic uremic syndrome in children in the United Kingdom and Ireland.
    Brocklebank V; Johnson S; Sheerin TP; Marks SD; Gilbert RD; Tyerman K; Kinoshita M; Awan A; Kaur A; Webb N; Hegde S; Finlay E; Fitzpatrick M; Walsh PR; Wong EKS; Booth C; Kerecuk L; Salama AD; Almond M; Inward C; Goodship TH; Sheerin NS; Marchbank KJ; Kavanagh D
    Kidney Int; 2017 Nov; 92(5):1261-1271. PubMed ID: 28750931
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association among Complement Factor H Autoantibodies, Deletions of CFHR, and the Risk of Atypical Hemolytic Uremic Syndrome.
    Jiang H; Fan MN; Yang M; Lu C; Zhang M; Liu XH; Ma L
    Int J Environ Res Public Health; 2016 Dec; 13(12):. PubMed ID: 27929404
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Atypical hemolytic uremic syndrome.
    Afshar-Kharghan V
    Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):217-225. PubMed ID: 27913483
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anti-complement-factor H-associated glomerulopathies.
    Durey MA; Sinha A; Togarsimalemath SK; Bagga A
    Nat Rev Nephrol; 2016 Sep; 12(9):563-78. PubMed ID: 27452363
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Complement Factor H-Related Protein 3 Serum Levels Are Low Compared to Factor H and Mainly Determined by Gene Copy Number Variation in CFHR3.
    Pouw RB; Brouwer MC; Geissler J; van Herpen LV; Zeerleder SS; Wuillemin WA; Wouters D; Kuijpers TW
    PLoS One; 2016; 11(3):e0152164. PubMed ID: 27007437
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Plasmodium falciparum blood stages acquire factor H family proteins to evade destruction by human complement.
    Rosa TF; Flammersfeld A; Ngwa CJ; Kiesow M; Fischer R; Zipfel PF; Skerka C; Pradel G
    Cell Microbiol; 2016 Apr; 18(4):573-90. PubMed ID: 26457721
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Successful therapy of C3Nef-positive C3 glomerulopathy with plasma therapy and immunosuppression.
    Häffner K; Michelfelder S; Pohl M
    Pediatr Nephrol; 2015 Nov; 30(11):1951-9. PubMed ID: 25986912
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An international consensus approach to the management of atypical hemolytic uremic syndrome in children.
    Loirat C; Fakhouri F; Ariceta G; Besbas N; Bitzan M; Bjerre A; Coppo R; Emma F; Johnson S; Karpman D; Landau D; Langman CB; Lapeyraque AL; Licht C; Nester C; Pecoraro C; Riedl M; van de Kar NC; Van de Walle J; Vivarelli M; Frémeaux-Bacchi V;
    Pediatr Nephrol; 2016 Jan; 31(1):15-39. PubMed ID: 25859752
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Current Understanding of the Role of Complement in IgA Nephropathy.
    Maillard N; Wyatt RJ; Julian BA; Kiryluk K; Gharavi A; Fremeaux-Bacchi V; Novak J
    J Am Soc Nephrol; 2015 Jul; 26(7):1503-12. PubMed ID: 25694468
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The major autoantibody epitope on factor H in atypical hemolytic uremic syndrome is structurally different from its homologous site in factor H-related protein 1, supporting a novel model for induction of autoimmunity in this disease.
    Bhattacharjee A; Reuter S; Trojnár E; Kolodziejczyk R; Seeberger H; Hyvärinen S; Uzonyi B; Szilágyi Á; Prohászka Z; Goldman A; Józsi M; Jokiranta TS
    J Biol Chem; 2015 Apr; 290(15):9500-10. PubMed ID: 25659429
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Competition between antagonistic complement factors for a single protein on N. meningitidis rules disease susceptibility.
    Caesar JJ; Lavender H; Ward PN; Exley RM; Eaton J; Chittock E; Malik TH; Goiecoechea De Jorge E; Pickering MC; Tang CM; Lea SM
    Elife; 2014 Dec; 3():. PubMed ID: 25534642
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A new paradigm: Diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury.
    Jodele S; Laskin BL; Dandoy CE; Myers KC; El-Bietar J; Davies SM; Goebel J; Dixon BP
    Blood Rev; 2015 May; 29(3):191-204. PubMed ID: 25483393
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The genetics and immunobiology of IgA nephropathy.
    Kiryluk K; Novak J
    J Clin Invest; 2014 Jun; 124(6):2325-32. PubMed ID: 24892706
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Complement factor H gene associations with end-stage kidney disease in African Americans.
    Bonomo JA; Palmer ND; Hicks PJ; Lea JP; Okusa MD; Langefeld CD; Bowden DW; Freedman BI
    Nephrol Dial Transplant; 2014 Jul; 29(7):1409-14. PubMed ID: 24586071
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Periodontal disease bacteria specific to tonsil in IgA nephropathy patients predicts the remission by the treatment.
    Nagasawa Y; Iio K; Fukuda S; Date Y; Iwatani H; Yamamoto R; Horii A; Inohara H; Imai E; Nakanishi T; Ohno H; Rakugi H; Isaka Y
    PLoS One; 2014; 9(1):e81636. PubMed ID: 24489644
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Determining the population frequency of the CFHR3/CFHR1 deletion at 1q32.
    Holmes LV; Strain L; Staniforth SJ; Moore I; Marchbank K; Kavanagh D; Goodship JA; Cordell HJ; Goodship TH
    PLoS One; 2013; 8(4):e60352. PubMed ID: 23613724
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Contribution of copy number variation in the regulation of complement activation locus to development of age-related macular degeneration.
    Schmid-Kubista KE; Tosakulwong N; Wu Y; Ryu E; Hecker LA; Baratz KH; Brown WL; Edwards AO
    Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5070-9. PubMed ID: 19553609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.